How to Conquer Coronavirus: Top 35 Treatments in Development
As the world scrambles to monitor and contain the COVID-19 outbreak, drug companies are racing to develop or repurpose treatments to combat the potential pandemic. The death toll continues to climb. The first U.S....
Improving Integrated Clinical Trial Management Systems through Blockchain
Clinical trials are an expensive stage in a pharmaceutical product’s development. According to a recent study,1 it costs more than $2.6 billion to bring a drug to market. R&D costs play a significant role,...
Anticancer siRNAs Delivered to Cells Using MOF Nanoparticles
Scientists from the University of Cambridge have developed a highly porous type of nanoparticle known as a metal-organic framework (MOF) that can deliver disease gene targeting small interfering RNAs (siRNAs) directly to cells. There...
Hyper-Long Telomeres Give Non-Genetically Modified Mice Longer, Healthier Lives
Scientists at the Spanish National Cancer Research Centre (CNIO) generated the first mice that have super-long telomeres in every one of their body cells. Studies with the animals showed that in comparison with mice...
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
Ask the average person on the street what they think of after hearing the phrase viral safety, and you will most likely be regaled with stories about scientists in hazmat suits saving Matt Damon...
Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic Health
An enzyme that fine-tunes the structure of ceramide lipid molecules could represent a promising new target for metabolic disorders including prediabetes, diabetes, and heart disease, according to a University of Utah Health-led research team....
Bioinformatics Tool Tracks Individual Gut Microbial Strain Changes After Antibiotic Use
Researchers at the University of Alabama at Birmingham (UAB) have provided new insights into how antibiotic use in humans can disrupt the communities of bacteria that reside in our gut systems. The team’s studies...
Potential Diabetes Target Makes Subtle Changes with Big Impact on Metabolic Health
An enzyme that fine-tunes the structure of ceramide lipid molecules could represent a promising new target for metabolic disorders including prediabetes, diabetes, and heart disease, according to a University of Utah Health-led research team....
Anticancer Immune Cells Identified Using Antigen Receptor Barcode Tracker
Australian scientists have developed a kind of barcode tracking system for cells that can identify rare immune system cells that are produced in response to cancer. The patented Repertoire and Gene Expression by Sequencing...
Invitrocue Leads Market With Personalised Oncology Solutions
Invitrocue Ltd (ASX:IVQ) chief executive officer Steven Fang speaks to Proactive Investors about the oncology-focused company's development of cancer treatments by testing specific drugs on laboratory-controlled micro-tumours. "We've been able to...
